diclofenac diethylamine
(ZQVZPANTCLRASL-UHFFFAOYSA-N)
Structure
- SMILES
- OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl.CCNCC
- Molecular Formula:
- C18H22Cl2N2O2
- Molecular Weight:
- 369.285
- Log P:
- 5.4438
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 3
- TPSA:
- 61.36
- CAS Number(s):
- 78213-16-8
Synonym(s)
1.
diclofenac diethylamine
External Link(s)
| MeSH | C000614065 |
| PubChem Compound | 115087 13365607 |
| KEGG | dr:D07817 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sinusitis | FAERS: 2 | US FAERS | |
| 2 | Concomitant disease aggravated | FAERS: 1 | US FAERS | |
| 3 | Epilepsy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Gastric ulcer | FAERS: 1 | US FAERS | |
| 6 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 7 | Incorrect product administration duration | FAERS: 1 | US FAERS | |
| 8 | Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Pruritus | FAERS: 1 | US FAERS | |
| 10 | Arthritis | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Back disorder | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Burning sensation | Canada Vigilance: 2 | Canada Vigilance | |
| 13 | Dementia | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Drug ineffective | Canada Vigilance: 34 | Canada Vigilance | |
| 15 | Dry skin | Canada Vigilance: 2 | Canada Vigilance | |
| 16 | Intentional product misuse | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Joint injury | Canada Vigilance: 1 | Canada Vigilance | |
| 18 | Myalgia | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Necrosis | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Product use in unapproved indication | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Skin irritation | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Skin necrosis | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Therapeutic product effect incomplete | Canada Vigilance: 2 | Canada Vigilance | |
| 25 | Therapeutic response unexpected | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.